Viemed Healthcare (VMD) FCF Margin (2018 - 2026)

Viemed Healthcare has reported FCF Margin for 9 years, with the latest figure at 6.88% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin rose 819.0% year-over-year to 6.88%; the trailing twelve-month figure through Mar 2026 stood at 19.07% (up 301.0% YoY), and the FY2025 full-year result was 18.02%, up 156.0% from the prior year.
• FCF Margin for Q1 2026 stood at 6.88%, down from 61.0% in the prior quarter.
• The five-year high for FCF Margin was 66.3% in Q4 2022, with the low at 25.82% in Q3 2022.
• Historically, FCF Margin has averaged 18.22% across 5 years, with a median of 18.91% in 2025.
• The largest YoY upside for FCF Margin was 5887 bps in 2023 against a maximum downside of 4015 bps in 2023.
• Viemed Healthcare's FCF Margin stood at 66.3% in 2022, then sank by 61 bps to 26.16% in 2023, then fell by 1 bps to 25.8% in 2024, then soared by 136 bps to 61.0% in 2025, then slumped by 89 bps to 6.88% in 2026.
• The last three FCF Margin figures came in at 6.88% (Q1 2026), 61.0% (Q4 2025), and 12.41% (Q3 2025), per Business Quant data.